Adenosarcoma of the uterus following tamoxifen treatment for breast cancer
- 1 March 1998
- journal article
- research article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 8 (2) , 168-171
- https://doi.org/10.1046/j.1525-1438.1998.09770.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trialThe Lancet, 1994
- Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *JNCI Journal of the National Cancer Institute, 1994
- Risk of endometrial cancer after tamoxifen treatment of breast cancerThe Lancet, 1994
- Uterine Malignant Mixed Mullerian Tumor in a Patient on Long-Term Tamoxifen Therapy for Breast CancerGynecologic Oncology, 1993
- Role of Prolonged Stimulation of Tamoxifen Therapy in the Etiology of Endometrial SarcomasGynecologic Oncology, 1993
- Uterine mullerian adenosarcoma following adenomyoma in a woman on tamoxifen therapyGynecologic Oncology, 1992
- Rapid growth of leiomyoma in patient receiving tamoxifenAmerican Journal of Obstetrics and Gynecology, 1992
- Mullerian adenosarcoma of the uterus: A clinicopathologic analysis of 100 cases with a review of the literatureHuman Pathology, 1990
- ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERSThe Lancet, 1989
- Adenofibroma and adenosarcoma of the uterus: A clinicopathologic study of 35 casesCancer, 1981